HIV drug resistance transmission threshold survey in Bangkok, Thailand

Antiviral Therapy

Volumn 13, Issue SUPPL. 2, 2008, Pages 109-113

  Sirivichayakul, Sunee ^a   Phanuphak, Praphan ^b   Pankam, Tippawan ^b   O Charoen, Rachanee ^b   Sutherland, Donald ^c   Ruxrungtham, Kiat ^a  

^a CHULALONGKORN UNIVERSITY   (Thailand)

^b THAI RED CROSS AIDS RESEARCH CENTRE   (Thailand)

^c WORLD HEALTH ORGANIZATION   (Switzerland)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIRETROVIRUS AGENT; LAMIVUDINE PLUS NEVIRAPINE PLUS STAVUDINE; PROTEINASE; RNA DIRECTED DNA POLYMERASE;

ADULT; ARTICLE; BLOOD DONOR; DISEASE TRANSMISSION; FEMALE; GENE MUTATION; GENOTYPE; HEALTH SURVEY; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTED PATIENT; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; SCALE UP; SEROCONVERSION; STRUCTURAL GENE; THAILAND; VIRUS LOAD; WORLD HEALTH ORGANIZATION; ANTIVIRAL RESISTANCE; ENZYMOLOGY; GENETICS; HEALTH; HEALTH CARE QUALITY; HIGHLY ACTIVE ANTIRETROVIRAL THERAPY; HUMAN IMMUNODEFICIENCY VIRUS; IMMUNOLOGY; MIDDLE AGED; MUTATION; PROSPECTIVE STUDY; PUBLIC HEALTH; STATISTICS; TIME; TREATMENT OUTCOME; VIROLOGY;

ADULT; ANTI-RETROVIRAL AGENTS; ANTIRETROVIRAL THERAPY, HIGHLY ACTIVE; BLOOD DONORS; DRUG RESISTANCE, VIRAL; FEMALE; GENOTYPE; HIV; HIV INFECTIONS; HIV PROTEASE; HIV REVERSE TRANSCRIPTASE; HIV SEROPOSITIVITY; HUMANS; MALE; MIDDLE AGED; MUTATION; NATIONAL HEALTH PROGRAMS; POPULATION SURVEILLANCE; PROGRAM EVALUATION; PROSPECTIVE STUDIES; THAILAND; TIME FACTORS; TREATMENT OUTCOME; URBAN HEALTH; WORLD HEALTH ORGANIZATION;

EID: 47249099863     PISSN: 13596535     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (15)

1. 2006 Report on the Global AIDS Epidemic, UNAIDS, May 2006. Available at: http://www.unaids.org
2. Phanuphak P, Locharernkul C, Panmoung W, Wilde H. A report of three cases of AIDS in Thailand. Asian Pac J Allergy Immunol 1985; 3:195-199.
3. Weniger BG, Limpakarnjanarat K, Ungchusak K, et al. The epidemiology of HIV infection and AIDS in Thailand. AIDS 1991; 5 Suppl 2:S71-S85.
4. Department of Disease Control, Thailand Ministry of Public Health (2006). Departmental Monthly Report. Department of Disease Control, Thailand Ministry of Public Health. October 2006.
5. WHO, Scaling up antiretroviral therapy in resource-limited settings: treatment guidelines for a public health approach; 2003 edition. Geneva: World Health Organization; 2004. Available at: http://www.who.int
6. Phanuphak P, Grayson ML, Sirivichayakul S, et al. A comparison of two dosing regimens of zidovudine in Thai adults with early symptomatic HIV infection. Conducting clinical HIV trials in South-East Asia. Aust NZ J Med 2000; 30:11-20.
7. Kroon ED, Ungsedhapand C, Ruxrungtham K, et al. A randomized, double-blind trial of half versus standard dose of zidovudine plus zalcitabine in Thai HIV-1-infected patients (study HIV-NAT 001). HIV Netherlands Australia Thailand Research Collaboation. AIDS 2000; 14:1349-1356.
8. Ruxrungtham K, Kroon ED, Teeratakulpisarn S, et al. A randomized, dose-finding study with didanosine plus stavudine versus didanosine alone in antiviral-naïve, HIV-infected Thai patients. AIDS 2000; 14:1375-1382.
9. WHO, Antiretroviral therapy for HIV infection in adults and adolescents in resource-limited settings: towards universal access, recommendations for a public health approach; 2006 revision. Geneva: World Health Organization; 2004. Available at: http://www.who.int
10. Sungkanuparph S, Manosuthi W, Kiertburanakul S, Piyavong B, Chumpathat N, Chantratita W. Options for a second-line antiretroviral regimen for HIV type 1-infected patients whose initial regimen of a fixed-dose combination of stavudine, lamivudine, and nevirapine fails. Clin Infect Dis 2007; 44:447-452.
11. Jourdain G, Ngo-Giang-Huong N, Le Coeur S, et al. Perinatal HIV prevention trial (Thailand) intrapartum exposure to nevirapine and subsequent maternal responses to nevirapine-based antiretroviral therapy. N Engl J Med 2004; 351:229-240.
12. Khongphattanayothin M, Tantipaibulvut S, Nookai S, Chunchee P, Kaldor J, Phanuphak P. Demographic predictors of a possible HIV test result among clients attending a large metropolitan voluntary counseling and testing centre in Thailand. HIV Med 2006; 7:281-284.
13. Shafer RW, Rhee S-Y, Pillay D, et al. HIV-1 protease and reverse transcriptase mutations for drug resistance surveillance. AIDS 2007; 21:215-223.
14. Myatt M, Bennett DE. A novel sequential sampling technique for the surveillance of transmitted HIV drug resistance by cross-sectional survey for use in low resource settings. Antivir Ther 2008; 13 Suppl 2:37-48.
15. Van Griensven F, Varangrat A, Wimonsate W, et al. HIV prevalence among populations of men who have sex with men - Thailand, 2003 and 2005. MMWR 2006; 55:844-848.